Analgesics is expected to see current value growth in 2023 and beyond, as the opportunities for consumers to get out and about are expected to return, and the number of inbound tourists is also expected to recover. However, analgesics is expected to face difficulty recovering to the 2019 level of sales in volume terms, as the number of consumers suffering from symptoms such as fever and pain is likely to be lower than pre-COVID-19, as telecommuting is expected to take hold, and the practices of hand washing and gargling, which have become routine since the pandemic, are expected to continue over the long term, limiting the communication of colds and flu.
New lifestyles triggered by COVID-19, such as longer time spent at home and lack of daily exercise, are expected to take root in the future. Therefore, topical analgesics/anaesthetics which claim to address problems in certain parts of the body, such shoulder and back aches, are expected to contribute to steady growth in domestic demand.
The stresses triggered by modern lifestyles were accelerated by the COVID-19 pandemic, such as longer or irregular working hours telecommuting. Meanwhile, digitisation for work and entertainment has increased consumers’ exposure to computers and smartphones, meaning that more people are suffering from frequent migraines and headaches.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Japan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Japan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!